New WHO advice vindicates UK vaccine strategy

The World Health Organization (WHO) has affirmed that the Oxford-AstraZeneca vaccine is safe for all adults. (AP Photo)
Short Url
Updated 11 February 2021
Follow

New WHO advice vindicates UK vaccine strategy

  • British PM welcomes announcement that Oxford jab safe for all adults, second dose should be delayed
  • WHO official: ‘No reason to expect efficacy substantially compromised in older people’

LONDON: New guidance from the World Health Organization (WHO) has affirmed the British view that the Oxford-AstraZeneca vaccine is safe for all adults, and that its second dose should be delayed.

The British strategy, of offering the jab to over 65s and delaying the second dose, was met with skepticism from some EU members, some of whom have banned over 65s from receiving the AstraZeneca vaccine, citing a lack of data proving its efficacy.

But new guidance from a WHO advisory group released on Thursday cited data showing good immune responses from older people from the jab.

“This suggests it is likely that the vaccine will be found to be efficacious in older persons,” the group said. “The trial data indicate that the vaccine is safe for this age group. Taking the totality of available evidence into account, the WHO recommends the vaccine for use in persons aged 65 years and older.”

The group also found that “vaccine efficacy tended to be higher when the interval between doses was longer,” and concluded that other countries should follow Britain’s dosing plans with the jab.

The WHO still says doses of the Pfizer-BioNTech vaccine should be given no more than six weeks apart, but added that these guidelines are open to the possibility of revision.

British Prime Minister Boris Johnson said it was “good to see” the WHO’s judgment, which will be taken as a vindication of the controversial decision to disregard manufacturer advice and delay doses between jabs in order to spread virus protection more widely.

The UK is among the world’s fastest vaccinating countries, having already inoculated over 13 million people, with a strategy of prioritizing the elderly and healthcare workers. 

Prof. Katherine O’Brien, director of the WHO’s immunization department, said: “There is no reason to expect that efficacy is substantially compromised in older people.”

Given that “the over-65s are at the very highest risk of severe disease and death (and we have) a product that has significant efficacy … there is no reason to constrain the AstraZeneca product from a general recommendation,” she added.


Moderate candidate wins emphatically over a populist in Portugal’s presidential runoff

Updated 5 sec ago
Follow

Moderate candidate wins emphatically over a populist in Portugal’s presidential runoff

LISBON: Center-left Socialist candidate António José Seguro recorded a thumping victory over hard-right populist André Ventura in Portugal’s runoff presidential election Sunday, according to official results with 99 percent of votes counted.
Seguro won a five-year term in Lisbon’s riverside “pink palace” with 66.7 percent of votes, compared with 33.3 percent for Ventura.
The ballot was an opportunity to test the depth of support for Ventura’s brash style, which has struck a chord with voters and helped make his Chega (Enough) party the second-biggest in the Portuguese parliament, as well as gauge the public appetite for Europe’s increasing shift to the right in recent years.
European Commission President Ursula von der Leyen congratulated Seguro and said on social media that “Portugal’s voice for our shared European values remains strong.”
Seguro, a longstanding Socialist politician, positioned himself as a moderate candidate who will cooperate with Portugal’s center-right minority government, repudiating Ventura’s anti-establishment and anti-immigrant tirades.
He won the backing of other mainstream politicians on the left and right who want to halt the rising populist tide.
In Portugal, the president is largely a figurehead with no executive power. Traditionally, the head of state stands above the political fray, mediating disputes and defusing tensions.
However, the president is an influential voice and possesses some powerful tools, being able to veto legislation from parliament, although the veto can be overturned. The head of state also possesses what in Portuguese political jargon is called an “atomic bomb,” the power to dissolve parliament and call early elections.
In May, Portugal held its third general election in three years in the country’s worst bout of political instability for decades, and steadying the ship is a key challenge for the next president.
Ventura, an eloquent and theatrical politician, rejected political accommodation in favor of a more combative stance.
Ventura said he will keep working to bring about a political “transformation” in Portugal.
“I tried to show there’s a different way … that we needed a different kind of president,” he told reporters.
Making it through to the runoff was already a milestone for Ventura and his party, which have recalibrated Portuguese politics.
One of Ventura’s main targets has been what he calls excessive immigration, as foreign workers have become more conspicuous in Portugal in recent years.
“Portugal is ours,” he said.
During the campaign, Ventura put up billboards across the country saying, “This isn’t Bangladesh” and “Immigrants shouldn’t be allowed to live on welfare.”
Although he founded his party less than seven years ago, its surge in public support made it the second-largest party in Portugal’s parliament in the May 18 general election.
Seguro will next month replace center-right President Marcelo Rebelo de Sousa, who has served the constitutional limit of two five-year terms.